Home
>
National Drug Code (NDC)
>
Lexapro
Lexapro - 0456-2020-01 - (ESCITALOPRAM OXALATE)
Drug Information of Lexapro
| Product NDC: | 0456-2020 |
| Proprietary Name: | Lexapro |
| Non Proprietary Name: | ESCITALOPRAM OXALATE |
| Active Ingredient(s): | 20 mg/1 & nbsp; ESCITALOPRAM OXALATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lexapro
| Product NDC: | 0456-2020 |
| Labeler Name: | Forest Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021323 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20020814 |
Package Information of Lexapro
| Package NDC: | 0456-2020-01 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (0456-2020-01) |
NDC Information of Lexapro
| NDC Code | 0456-2020-01 |
| Proprietary Name | Lexapro |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (0456-2020-01) |
| Product NDC | 0456-2020 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ESCITALOPRAM OXALATE |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20020814 |
| Marketing Category Name | NDA |
| Labeler Name | Forest Laboratories, Inc. |
| Substance Name | ESCITALOPRAM OXALATE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |
